Patent offices to revise stem cell guidance post-Brüstle

November 02, 2011

Patent offices in Europe are considering whether to change their approach to the patenting of stem cell-related inventions following a Court of Justice ruling last month

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Three ITC trends shaping IP investigations

Counsel are eying domestic industry, concurrent PTAB proceedings and heightened scrutiny of cases before institution

Rani Mehta, March 24, 2023

Jack Daniel’s SCOTUS hearing leaves counsel swaying

Jack Daniel’s has a good chance of winning its dispute over dog toys, but SCOTUS will still want to protect free speech, predict sources

Rani Mehta, March 24, 2023

US Copyright Office’s AI guidance receives mixed reviews

AI users and lawyers discuss why the rulebook for registering AI-generated content may create problems and needs further work

Sukanya Sarkar, March 24, 2023

This week on MIP: EPO publishes G2/21, UK High Court backs Gilead

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

Rory O’Neill, March 24, 2023

EPO appeals board places conditions on post-application evidence

A technical effect must still be evident in the original patent filing, the EBoA said in its G2/21 decision today, March 23

Rory O’Neill, March 23, 2023

Different fresh chocolate ready for sale

What’s in a name? Why the lookalike argument needs to change

Brands should not be deterred from pursuing lookalike producers, and an unfair advantage claim could be the key, say Emma Teichmann and Geoff Steward at Stobbs

Geoff Steward, March 23, 2023

InterDigital v Lenovo ruling prompts SEP owner rethink

Justice Mellor’s highly anticipated ruling surprised SEP owners and reassured implementers that the UK may not be so hostile after all

Rory O’Neill, March 23, 2023

Feb 19, 2020 Foster City / CA / USA - Gilead sign at their headq

High Court backs Gilead but issues case timeline warning

The England and Wales High Court's judgment comes ahead of a separate hearing concerning one of the patents-in-suit at the EPO

Rory O’Neill, March 23, 2023

What India’s legal market opening means for foreign IP firms

While the rules allow foreign firms to open local offices and offer IP services, a ban on litigation and practising Indian law could mean little will change

Sukanya Sarkar, March 23, 2023